- Home
- SGMT vs MBCN Comparison
SGMT vs MBCN Comparison
Compare SGMT & MBCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- MBCN
- Stock Information
- Founded
- SGMT 2006
- MBCN 1901
- Country
- SGMT United States
- MBCN United States
- Employees
- SGMT N/A
- MBCN N/A
- Industry
- SGMT
- MBCN Major Banks
- Sector
- SGMT
- MBCN Finance
- Exchange
- SGMT Nasdaq
- MBCN Nasdaq
- Market Cap
- SGMT 230.3M
- MBCN 236.1M
- IPO Year
- SGMT 2023
- MBCN N/A
- Fundamental
- Price
- SGMT $7.11
- MBCN $30.29
- Analyst Decision
- SGMT Strong Buy
- MBCN Hold
- Analyst Count
- SGMT 7
- MBCN 1
- Target Price
- SGMT $26.57
- MBCN $33.00
- AVG Volume (30 Days)
- SGMT 601.4K
- MBCN 7.1K
- Earning Date
- SGMT 08-13-2025
- MBCN 10-16-2025
- Dividend Yield
- SGMT N/A
- MBCN 2.77%
- EPS Growth
- SGMT N/A
- MBCN 16.03
- EPS
- SGMT N/A
- MBCN 2.25
- Revenue
- SGMT N/A
- MBCN $70,503,000.00
- Revenue This Year
- SGMT N/A
- MBCN $18.85
- Revenue Next Year
- SGMT N/A
- MBCN $6.69
- P/E Ratio
- SGMT N/A
- MBCN $13.46
- Revenue Growth
- SGMT N/A
- MBCN 5.64
- 52 Week Low
- SGMT $1.73
- MBCN $22.74
- 52 Week High
- SGMT $11.41
- MBCN $34.00
- Technical
- Relative Strength Index (RSI)
- SGMT 39.46
- MBCN 51.69
- Support Level
- SGMT $7.01
- MBCN $28.83
- Resistance Level
- SGMT $7.68
- MBCN $34.00
- Average True Range (ATR)
- SGMT 0.51
- MBCN 1.26
- MACD
- SGMT -0.02
- MBCN 0.02
- Stochastic Oscillator
- SGMT 39.03
- MBCN 37.65
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About MBCN Middlefield Banc Corp.
Middlefield Banc Corp is a bank holding company. It offers customers, banking services including checking, savings, negotiable order of withdrawal (NOW) accounts, money market accounts, time deposits, commercial loans, real estate loans, a variety of consumer loans, safe deposit facilities, and travelers' checks. It also provides online banking and bill payment services to individuals and online cash management services to business customers.